Europe Human Milk Oligosaccharides Market Size, Share & Industry Trends Analysis Report By Application, By Type (2'FL, 3'FL, 3'SL, and 6'SL), By Concentration (Neutral, and Acidic), By Country and Growth Forecast, 2023 - 2030
The Europe Human Milk Oligosaccharides Market would witness market growth of 22.4% CAGR during the forecast period (2023-2030).
The market is expected to witness significant revenue generation during the forecast period, owing to an increase in application scope in functional food & beverages and infant formula, rapid technological advancement in the product line, rise in health awareness, and rapid development of the dairy industry. HMOs are essential components of human milk that are available in a variety of concentrations and compositions. They are novel ingredients that require regulatory approval. With the upsurge in demand for HMOs, two HMOs have undergone the novel food safety assessment in Europe, resulting in a positive evaluation outcome and approval by the European Commission.
HMOs have been used in infant formula and human milk for a prolonged period. The compositions, however, differ, and HMOs are not found in other foods. The path to the market for new and novel HMOs as a dietary supplement is to have GRAS self-affirmed for use in food and subsequently use it in the same form as a dietary supplement. 2'-O-fucosyllactose, 2'-fucosyllactose, and lacto-N-neotetraose have all received such notices.
The German consumer base is known for its health-conscious preferences. HMO-enriched fresh milk aligns with the trend of seeking functional and health-promoting ingredients, attracting consumers looking for products with added nutritional value. Fresh milk with added HMOs can extend beyond infant nutrition to include products aimed at maternal health during pregnancy and lactation. This expansion broadens the HMOs in dairy products. The aforementioned factors will drive the market growth in this region.
The Germany market dominated the Europe Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $54,123.6 Thousand by 2030. The UK market is exhibiting a CAGR of 21.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 23.2% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A)
Scope of the Study
Market Segments covered in the Report:
By Application
- Infant Formula
- Functional Food & Beverages
- Food Supplements
- Others (Clinical Nutrition & Pharmaceuticals)
- 2'FL
- 3'FL
- 3'SL
- 6'SL
- Neutral
- Acidic
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Koninklijke DSM N.V.
- BASF SE
- Chr. Hansen Holding A/S
- DuPont de Nemours, Inc.
- Nestle S.A
- Inbiose NV
- Biosynth AG
- Abbott Laboratories
- Royal FrieslandCampina N.V.
- Dextra Laboratories Ltd (ICE S.p.A)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Human Milk Oligosaccharides Market, by Application
- 1.4.2 Europe Human Milk Oligosaccharides Market, by Type
- 1.4.3 Europe Human Milk Oligosaccharides Market, by Concentration
- 1.4.4 Europe Human Milk Oligosaccharides Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market At a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Trials and Approvals
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.4 Porter Five Forces Analysis
- Chapter 5. Europe Human Milk Oligosaccharides Market, by Application
- 5.1 Europe Infant Formula Market, by Country
- 5.2 Europe Functional Food & Beverages Market, by Country
- 5.3 Europe Food Supplements Market, by Country
- 5.4 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
- Chapter 6. Europe Human Milk Oligosaccharides Market, by Type
- 6.1 Europe 2'FL Market, by Country
- 6.2 Europe 3'FL Market, by Country
- 6.3 Europe 3'SL Market, by Country
- 6.4 Europe 6'SL Market, by Country
- Chapter 7. Europe Human Milk Oligosaccharides Market, by Concentration
- 7.1 Europe Neutral Market, by Country
- 7.2 Europe Acidic Market, by Country
- Chapter 8. Europe Human Milk Oligosaccharides Market, by Country
- 8.1 Germany Human Milk Oligosaccharides Market
- 8.1.1 Germany Human Milk Oligosaccharides Market, by Application
- 8.1.2 Germany Human Milk Oligosaccharides Market, by Type
- 8.1.3 Germany Human Milk Oligosaccharides Market, by Concentration
- 8.2 UK Human Milk Oligosaccharides Market
- 8.2.1 UK Human Milk Oligosaccharides Market, by Application
- 8.2.2 UK Human Milk Oligosaccharides Market, by Type
- 8.2.3 UK Human Milk Oligosaccharides Market, by Concentration
- 8.3 France Human Milk Oligosaccharides Market
- 8.3.1 France Human Milk Oligosaccharides Market, by Application
- 8.3.2 France Human Milk Oligosaccharides Market, by Type
- 8.3.3 France Human Milk Oligosaccharides Market, by Concentration
- 8.4 Russia Human Milk Oligosaccharides Market
- 8.4.1 Russia Human Milk Oligosaccharides Market, by Application
- 8.4.2 Russia Human Milk Oligosaccharides Market, by Type
- 8.4.3 Russia Human Milk Oligosaccharides Market, by Concentration
- 8.5 Spain Human Milk Oligosaccharides Market
- 8.5.1 Spain Human Milk Oligosaccharides Market, by Application
- 8.5.2 Spain Human Milk Oligosaccharides Market, by Type
- 8.5.3 Spain Human Milk Oligosaccharides Market, by Concentration
- 8.6 Italy Human Milk Oligosaccharides Market
- 8.6.1 Italy Human Milk Oligosaccharides Market, by Application
- 8.6.2 Italy Human Milk Oligosaccharides Market, by Type
- 8.6.3 Italy Human Milk Oligosaccharides Market, by Concentration
- 8.7 Rest of Europe Human Milk Oligosaccharides Market
- 8.7.1 Rest of Europe Human Milk Oligosaccharides Market, by Application
- 8.7.2 Rest of Europe Human Milk Oligosaccharides Market, by Type
- 8.7.3 Rest of Europe Human Milk Oligosaccharides Market, by Concentration
- Chapter 9. Company Profiles
- 9.1 Inbiose NV
- 9.1.1 Company Overview
- 9.1.2 SWOT Analysis
- 9.2 Biosynth AG
- 9.2.1 Company Overview
- 9.2.2 SWOT Analysis
- 9.3 Dextra Laboratories Ltd (ICE S.p.A)
- 9.3.1 Company Overview
- 9.4 Koninklijke DSM N.V.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Trials and Approvals:
- 9.4.5.2 Acquisition and Mergers:
- 9.4.6 SWOT Analysis
- 9.5 BASF SE
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Product Launches and Product Expansions:
- 9.5.1 SWOT Analysis
- 9.6 Chr. Hansen Holding A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segment & Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Trials and Approvals:
- 9.6.5.2 Acquisition and Mergers:
- 9.7 DuPont de Nemours, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.6 SWOT Analysis
- 9.8 Nestle S.A
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Product Launches and Product Expansions:
- 9.8.6 SWOT Analysis
- 9.9 Abbott Laboratories
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Royal FrieslandCampina N.V.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Partnerships, Collaborations, and Agreements:
- 9.10.5.2 Trials and Approvals:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook